A Tribute to Franz Halberg, MD

Dr Franz Halberg, a towering figure in cardiovascular research who founded and developed the new science of modernized chronobiology, passed away a month shy of 94 years of age on June 9, 2013. The chronobiological vocabulary and ambulatory monitoring methods were his original conceptions. Dr Halberg’s international stature and contributions to hypertension research through chronobiological methods were monumental, and we pay our respects to this outstanding scientist, educator, and scientific father and his dedication to the advancement of heart attack and stroke victims, hypertension research through chronobiological methods in individual monitoring, analyses, and interpretation in variations as a function of Time. In the early stages of his professional life, his keen observations of biological variations in living beings enabled him to find periodicities shared between biological systems and their broad environments, influenced by the sun and the cosmos, leading to chronomics (broad time structures beyond circadian rhythms). Biological time structures (clock hours) and chronomes are considered essential parameters in blood pressure monitoring, as well as in neurohormonal rhythms and other organs/systemic variations. The impact Dr Halberg had in science stemmed not only from his original findings but also from his vision of their implications that led beyond a scientific breakthrough to a new way of thinking as a truly great scientist. His lifetime of hard work after his medical education and training seeking optimal configurations of the time structure has contributed to some of the greatest advancements in the modern scientific world and standardized clinical practice, especially in hypertension. His research on timing guided by the circadian clock observed early changes in blood pressure and heart rate variability, especially large fluctuations in amplitudes and shift changes in peak hours among heart attack and stroke victims, and cancer patients. The changed rhythms can be detected during subclinical stages by ambulatory monitoring, …